15 results on '"Nitta, Hideaki"'
Search Results
2. The Presence of M Protein Is Strongly Associated with Very Poor Prognosis in Patients with Extranodal Diffuse Large B-Cell Lymphoma
3. 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
4. Rituximab Maintenance Therapy Is an Effective Therapy in over-Sixties with Mantle Cell Lymphoma
5. Elevated CRP Is Associated with Longer Survival of PTCL-NOS in Peripheral T-Cell Lymphomas: A Single Institution Research
6. Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified
7. Higher Titer of Epstein-Barr Virus Nuclear Antigen Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified
8. R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL
9. ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma
10. Is Radiation Therapy Effective for DLBCL As a Salvage after Chemotherapy?: A Study of 180 Diffuse Large B Cell Lymphoma (DLBCL) Cases at a Single Institution
11. RT-DeVIC Therapy Is Effective for Localized NK/T Cell Lymphoma Patiens
12. Ocular Adnexal Lymphomas (OALs) At Conjunctiva Present a Remarkable Good Prognosis : Oals Study Of 83 Cases At a Single Institution
13. Numbers and Percentages Of Peripheral Monocytes Is a Prognostic Marker For CNS Involvement In Diffuse Large B-Cell Lymphoma
14. Expansion of CD8+/perforin+ T-Cell Subset in Patients Predicts Response to Cyclosporin A Therapy in Patients with Erythroid Hypoplasia/Aplasia
15. Significance of Serum Soluble IL-2R in DLBCL and FL Is Different from That in ATL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.